Utilisation des antifongiques dans le traitement des candidoses systémiques : antifongigramme, point sur les résistances, données pharmacologiques
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Annales Françaises dʼAnesthésie et de Réanimation
- Vol. 20 (4) , 389-393
- https://doi.org/10.1016/s0750-7658(01)00373-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Introduction to Antifungal DrugsClinical Infectious Diseases, 2000
- Lipid Formulations of Amphotericin B: Clinical Efficacy and ToxicitiesClinical Infectious Diseases, 1998
- AmBisome (Liposomal Amphotericin B): A Comparative ReviewThe Journal of Clinical Pharmacology, 1998
- Systemic Antifungal AgentsDrug Safety, 1998
- Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patientsAntimicrobial Agents and Chemotherapy, 1997
- Overview of Oral Azole Drugs as Systemic Antifungal TherapySeminars in Respiratory and Critical Care Medicine, 1997
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Infection Due to Fluconazole-Resistant Candida in Patients with AIDS: Prevalence and MicrobiologyClinical Infectious Diseases, 1997
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993
- Nosocomial infection rates in adult and pediatric intensive care units in the United StatesThe American Journal of Medicine, 1991